MST Vitamin D3 K2 MK7 120 Capsules

MST Vitamin D3 K2 MK7 capsules contain 2000 IU (International Units) of vitamin D3 per capsule.
The form of vitamin K2 used in this product is menaquinone-7 (MK-7).

MST Vitamin D3 K2 MK7 capsules should ideally be taken after breakfast, with one capsule swallowed with plenty of liquid (200 ml). The recommended daily intake should not be exceeded.

The capsule shell contains gelatin, glycerin, and purified water as additional ingredients.

The combination of vitamins D3, K2, and MK-7 in the product MST Vitamin D3 K2 MK7 significantly supports cardiovascular function through a synergistic interaction in regulating calcium metabolism. While vitamin D3 promotes the absorption of calcium from the intestines into the bloodstream, vitamin K2 in its highly effective MK-7 form ensures that this calcium is specifically incorporated into the bone matrix and does not accumulate as plaque in the arterial walls. By activating matrix Gla protein, vitamin K2 plays a crucial role in maintaining vascular elasticity and preventing dangerous vascular calcification, thus reducing the risk of high blood pressure and other cardiovascular problems. With regard to blood clotting, vitamin K plays a central role in the synthesis of clotting factors in the liver, with the MK-7 variant ensuring a particularly constant supply due to its long half-life and high bioavailability, which both supports normal blood clotting and optimizes the protection of blood vessels against miscalculations.

Vitamin K2 in its MK-7 form activates the protein osteocalcin, which is responsible for the incorporation of calcium into the bone matrix, thus supporting bone density. The interaction with vitamin D3 is crucial, as vitamin D3 promotes calcium absorption in the intestine and the formation of calcium-binding proteins, while vitamin K2 (via the activation of matrix Gla protein) ensures that this calcium is transported to the bones and does not accumulate as calcium deposits in the arterial walls.